Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis.
- 2019-09-23
- Clinical Trial
- Digestive diseases and sciences 65(4)
- Grettel García-Collinot
- Eduardo Osiris Madrigal-Santillán
- Michel A Martínez-Bencomo
- Rosa A Carranza-Muleiro
- Luis J Jara
- Olga Vera-Lastra
- Daniel H Montes-Cortes
- Gabriela Medina
- María Pilar Cruz-Domínguez
- PubMed: 31549334
- DOI: 10.1007/s10620-019-05830-0
- High evidence
- Rigorous Journal
- Clinical
Reductions in expired hydrogen at 45 to 60 min were as follows: M + SB 48% and 44%, M 18% and 20%, and SB 53% and 60% at the first and second months, respectively (p < 0.01).
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes